Skip to main navigation Skip to search Skip to main content

Clinical and functional characterization of germline PIK3CA variants in patients with PIK3CA-related overgrowth spectrum disorders

  • Jessica A. Cooley Coleman
  • , Jennifer M. Gass
  • , Sujata Srikanth
  • , Rini Pauly
  • , Catherine A. Ziats
  • , David B. Everman
  • , Steven A. Skinner
  • , Shannon Bell
  • , Raymond J. Louie
  • , Lauren Cascio
  • , Wesley G. Patterson
  • , Julie R. Jones
  • , Nataliya Di Donato
  • , Roger E. Stevenson
  • , Luigi Boccuto
  • Greenwood Genetics Center
  • Florida Cancer Specialists & Research Institute
  • Clemson University
  • University of Texas at Austin
  • Technische Universität Dresden

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Mosaic variants in the PIK3CA gene, encoding the catalytic subunit of phosphoinositide 3-kinase (PI3K), produce constitutive PI3K activation, which causes PIK3CA-related overgrowth spectrum disorders. To date, fewer than 20 patients have been described with germline alterations in PIK3CA. In this study, we describe three unrelated individuals with overgrowth and germline PIK3CA variants. These variants were discovered through whole-exome sequencing and confirmed as germline by testing multiple tissue types, when available. Functional analysis using Patient 1’s fibroblast cell line and two previously reported patients’ cell lines showed increased phosphorylation of AKT during cellular starvation revealing constitutive activation of the phosphoinositide-3-kinase/protein kinase B/mechanistic target of rapamycin (PI3K/AKT/mTOR) pathway. Alternatively, stimulation of the cells by fetal bovine serum produced a reduced response, indicating an activated status of the PI3K complex reducing the pathway response to further external stimulation. Additional studies utilizing Biolog Phenotype Microarray technology indicated reduced energy production when cells were exposed to growth factors stimulating the PI3K/AKT/mTOR pathway, confirming the trend observed in the AKT phosphorylation test after stimulation. Furthermore, treatment with inhibitors of the PI3K/AKT/mTOR pathway rescued the normal energy response in the patients’ cells. Collectively, these data demonstrate that disease-causing germline PIK3CA variants have a functional consequence, similar to mosaic variants in the PI3K/AKT/mTOR pathway.

Original languageEnglish
Pages (from-to)1457-1465
Number of pages9
JournalHuman Molecular Genetics
Volume32
Issue number9
DOIs
StatePublished - 1 May 2023
Externally publishedYes

Fingerprint

Dive into the research topics of 'Clinical and functional characterization of germline PIK3CA variants in patients with PIK3CA-related overgrowth spectrum disorders'. Together they form a unique fingerprint.

Cite this